New Treatment Approach for Difficult High Blood Pressure
TL;DR Summary
AstraZeneca's experimental drug Baxdrostat shows promise in treating resistant high blood pressure, potentially offering a new approach for patients unresponsive to existing medications, with significant blood pressure reductions observed in a recent trial.
Topics:top-news#astrazeneca#baxdrostat#cardiovascular-risk#health#high-blood-pressure#hypertension-treatment
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
5 min
vs 6 min read
Condensed
97%
1,066 → 33 words
Want the full story? Read the original article
Read on Yahoo News Singapore